Opin vísindi
Metachronous Colorectal Cancer in Icelandic MSH6 and PMS2 Lynch Syndrome Carriers in 1955-2017 : A Population-based Study
- Opin vísindi
- →
- IRIS
- →
- IRIS
- →
- Skoða verk
JavaScript is disabled for your browser. Some features of this site may not work without it.
| Titill: | Metachronous Colorectal Cancer in Icelandic MSH6 and PMS2 Lynch Syndrome Carriers in 1955-2017 : A Population-based Study |
| Höfundur: |
|
| Útgáfa: | 2023-06 |
| Tungumál: | Enska |
| Umfang: | 164751 |
| Deild: | Faculty of Medicine Other departments |
| Birtist í: | Gastroenterology; 164(7) |
| ISSN: | 0016-5085 |
| DOI: | 10.1053/j.gastro.2023.02.007 |
| Efnisorð: | Meltingarlæknisfræði; Meinafræði; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics; Colorectal Neoplasms/genetics; DNA Mismatch Repair; Germ-Line Mutation; Humans; Iceland/epidemiology; Mismatch Repair Endonuclease PMS2/genetics; MutL Protein Homolog 1/genetics; MutS Homolog 2 Protein/genetics; Gastroenterology; Hepatology |
| URI: | https://hdl.handle.net/20.500.11815/4170 |
Tilvitnun:Andesdottir , A K , Einarsson , H , Jonsdottir , H , Jónasson , J G , Björnsson , E S & Haraldsdóttir , S 2023 , ' Metachronous Colorectal Cancer in Icelandic MSH6 and PMS2 Lynch Syndrome Carriers in 1955-2017 : A Population-based Study ' , Gastroenterology , vol. 164 , no. 7 , pp. 1314-1316.e1 . https://doi.org/10.1053/j.gastro.2023.02.007
|
|
Athugasemdir:Funding Information: Funding The study was partially funded by the Research Fund at Landspitali University Hospital. The funder had no role in the design of the study, collection, analysis, and interpretation of the data or in writing the manuscript.
|
|
Skrár
Þetta verk birtist í eftirfarandi safni/söfnum:
Verwandte Dokumente
Anzeige der Dokumente mit ähnlichem Titel, Autor, Urheber und Thema.
-
(2022-01-10)Thousands of non-coding variants have been associated with increased risk of human diseases, yet the causal variants and their mechanisms-of-action remain obscure. In an integrative study combining massively parallel reporter assays (MPRA), expression ... -
(2021-06-17)While the major drivers of melanoma initiation, including activation of NRAS/BRAF and loss of PTEN or CDKN2A, have been identified, the role of key transcription factors that impose altered transcriptional states in response to deregulated signaling ...
-
(2022-04-25)Objectives To find causal genes for rheumatoid arthritis (RA) and its seropositive (RF and/or ACPA positive) and seronegative subsets. Methods We performed a genome-wide association study (GWAS) of 31 313 RA cases (68% seropositive) and ∼1 million ...